Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma

NCT06933394 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Arsenic trioxide
DRUG: MAPK inhibitors
DRUG: Chemotherapy

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University